Alkermes Seeking Partner For Long-Acting Alcoholism Agent Vivitrex
Alkermes is in discussions with potential co-promotion partners for its long-lasting naltrexone injection Vivitrex for the treatment of alcohol addiction
You may also be interested in...
Alkermes is confident that Risperdal Consta will ultimately be reimbursed by all 50 state Medicaid programs
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials